BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8761715)

  • 1. Solving the dilemma of antimycobacterial chemotherapy.
    Rastogi N; Falkinham JO
    Res Microbiol; 1996; 147(1-2):7-10. PubMed ID: 8761715
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
    Agins BD; Berman DS; Spicehandler D; el-Sadr W; Simberkoff MS; Rahal JJ
    J Infect Dis; 1989 Apr; 159(4):784-7. PubMed ID: 2926169
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of disseminated Mycobacterium avium complex disease: a clinician's perspective.
    Benson CA
    Res Microbiol; 1996; 147(1-2):16-24. PubMed ID: 8761717
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and treatment of Mycobacterium avium complex infection.
    Mangura BT; Reichman LB
    Res Microbiol; 1994; 145(3):181-7. PubMed ID: 7809470
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity.
    Rastogi N; Barrow WW
    Res Microbiol; 1994; 145(3):167-8. PubMed ID: 7809466
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases].
    Saint-Marc T; Marneff E; Touraine JL
    Presse Med; 1993 Dec; 22(38):1903-7. PubMed ID: 8121903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.
    Heifets LB
    Res Microbiol; 1994; 145(3):188-96. PubMed ID: 7809471
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterium avium-intracellulare infection in the acquired immunodeficiency syndrome.
    Scoular A; French P; Miller R
    Br J Hosp Med; 1991 Nov; 46(5):295-300. PubMed ID: 1958928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
    AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials in Mycobacterium avium therapy: lessons to take home.
    Dautzenberg B
    Res Microbiol; 1994; 145(3):197-206. PubMed ID: 7809472
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of disease progress in Mycobacterium avium-infected AIDS patients.
    Hoffner SE; Källenius G; Svenson SB
    Res Microbiol; 1992 May; 143(4):391-8. PubMed ID: 1455066
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary clofazimine crystals in two patients with the acquired immunodeficiency syndrome.
    Alfandari S; Chidiac C; Guery B; Senneville E; Mouton Y; Vinocour D
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):88-9. PubMed ID: 9441067
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo synergistic effect of isoniazid with streptomycin and clofazimine against Mycobacterium avium complex (MAC).
    Reddy MV; Srinivasan S; Gangadharam PR
    Tuber Lung Dis; 1994 Jun; 75(3):208-12. PubMed ID: 7919314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy with isoniazid, rifampicin and pyrazinamide.
    Campbell IA
    Bull Int Union Tuberc Lung Dis; 1988 Dec; 63(4):63. PubMed ID: 3228612
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the prevention and treatment of Mycobacterium avium disease.
    Horsburgh CR
    N Engl J Med; 1996 Aug; 335(6):428-30. PubMed ID: 8663875
    [No Abstract]   [Full Text] [Related]  

  • 17. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
    Hoy J; Mijch A; Sandland M; Grayson L; Lucas R; Dwyer B
    J Infect Dis; 1990 Apr; 161(4):801-5. PubMed ID: 2156947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of mycobacterial infections in HIV infection.
    Coker RJ; Hellyer TJ; Brown IN; Weber JN
    Res Microbiol; 1992 May; 143(4):377-81. PubMed ID: 1455064
    [No Abstract]   [Full Text] [Related]  

  • 19. Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient.
    Bachelez H; Ducloy G; Pinquier L; Rouveau M; Sibilla J; Dubertret L
    Br J Dermatol; 1996 Apr; 134(4):801-3. PubMed ID: 8733397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
    Gordon SM; Horsburgh CR; Peloquin CA; Havlik JA; Metchock B; Heifets L; McGowan JE; Thompson SE
    J Infect Dis; 1993 Dec; 168(6):1559-62. PubMed ID: 8245546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.